Protective effect of Luffa acutangula extracts on gastric ulceration in NIDDM rats: Role of gastric mucosal glycoproteins and antioxidants  by Pimple, B.P. et al.
610 Asian Pacific Journal of Tropical Medicine (2012)610-615
Document heading          doi:  
Protective effect of Luffa acutangula extracts on gastric ulceration in 
NIDDM rats: Role of gastric mucosal glycoproteins and antioxidants
B. P. Pimple1*, P. V. Kadam2, M. J. Patil2
1P. E. Society’s Modern College of Pharmacy, Nigdi, Pune, Maharashtra, India. 411044 and Jawaharlal Nehru Technological University, 
Hyderabad, Andhra Pradesh, India
2Marathwada Mitra Mandal’s College of Pharmacy, Thergaon, Pune, Maharashtra, India 411033
 Contents lists available at ScienceDirect
Asian Pacific Journal of Tropical Medicine
journal homepage:www.elsevier.com/locate/apjtm
ARTICLE INFO                           ABSTRACT
Article history:
Received 10 March 2012
Received in revised form 15 May 2012
Accepted 15 July 2012







  *Corresponding author: B. P. Pimple, P. E. Society’s Modern College of Pharmacy, 
Nigdi, Pune, Maharashtra, India 411044. 
     Tel: +9199707830030
     Fax: +912227661314
     E-mail: bhushanppimple@rediffmail.com
1. Introduction
  Type II diabetes mellitus is one of the chronic disorders 
marked by disturbance in metabolism of carbohydrates 
and fats. It represents a severe setback of public health, 
as it accounts for substantial portion of national health 
expenditures globally in most of the countries. Diabetes 
still continues to amplify in number and significance in 
the developing countries. According to a study the diabetic 
population is expected to grow up to 552 million by 2030[1]. 
Another survey conducted on adult diabetic population 
(aged 20-79 years), revealed the presence of 285 million 
diabetic adults in 2010, and will amplify to 439 million by 
2030[2]. Inspite of the availability of beneficial treatments 
to avoid or delay chief complications, diabetes still places 
a massive burden on both patients and the health care 
system[3]. 
  Experimental induction of type II diabetes using 
streptozotocin-nicotinamide has been proved to be an 
efficient model to evaluate the efficiency of antidiabetic 
drugs[4]. Research has already proved that the gastric 
mucosa of diabetic rats is highly susceptible to acute 
injuries and considerably impairs ulcer healing[5]. 
  Since time immemorial, numerous plants species have 
been identified worldwide for antidiabetic and antiulcer 
activity[6]. Luffa acutangula (L. acutangula) Linn. var. 
amara Roxb. fruits have recently been proved to be 
effective in the management of diabetes, stress, gastric 
complications and respiratory disorders[7,8]. 
  The present study deals with comparative effect of 
methanolic and aqueous extracts of L. acutangula (LA) fruits 
in the treatment of ulcers in diabetic rats. LA extracts were 
administered in different doses (100, 200 and 400 mg/kg, p.o.)
to investigate their ulcer healing potential. Using aspirin for 
the induction gastric ulcer in streptozotocin (STZ)-induced 
type II diabetes, our work for the first time demonstrates 
that the L. acutangula stimulates the healing of gastric 
ulcer in diabetes. 
Objective: To study the comparative gastroprotective effect of Luffa acutangula methanolic 
extract (LAM) and aqueous extract (LAW) on type II diabetes rats. Methods: Streptozotocin (65 
mg/kg, i.p.) along with nicotinamide (120 mg/kg, i.p.) was used to induce non insulin dependent 
diabetes mellitus (NIDDM) in rats. A daily oral dose of aspirin (200 mg/kg, i.p.) was administered 
for initial seven days to induce gastric ulcerations in the diabetic rats. LAM and LAW were 
administered orally in the doses of 100, 200 and 400 mg/kg once daily for 21 days. Glibenclamide 
and ranitidine were used as standards for comparing the antidiabetic and antiulcer effect 
respectively. Results: LAM significantly (P<0.01) increased mucosal glycoprotein and antioxidant 
enzyme level in gastric mucosa of diabetic rats than LAW (P <0.05). LAM was efficient in reversing 
the delayed healing of gastric ulcer in diabetic rats close to the normal level. LAM exhibited 
better ulcer healing effect than glibenclamide and LAW, because of its both antihyperglycemic 
and mucosal defensive actions. Conclusions: Thus, LAM is proved to be a better alternative for 
treating gastric ulcers co-occurring with diabetes.
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2. Material and methods
2.1. Plant material
  The dried fruit pulp of L. acutangula Linn. var. amara 
Roxb. were obtained from the local markets of Pune and 
were authenticated by Botanical Survey of India, Western 
Circle, Pune with voucher specimen No. LABHP-1.
2.2. Preparation of extracts
  Methanolic extract (LAM) and aqueous extracts (LAW): 
The fresh L. acutangula fruits were grated, dried in shade 
and coarsely powdered. The powder was defatted with 
petroleum ether and then extracted by methanol in a Soxhlet 
apparatus. The aqueous extract was prepared by maceration 
with distilled water for 24 h. The extracts were concentrated 
under reduced pressure and were stored at 8-10 ℃ 
throughout the study[7]. The yield of LAM and LAW were 
2.31% w/w and 7.18% w/w, respectively. 
2.3. Chemicals and reagents 
  STZ and nicotinamide were obtained from Sigma-Aldrich, 
USA. Analytical grade methanol (99.9% v/v) and other 
chemicals were procured from Merck, USA.
2.4. Animals 
  Albino mice (20-22 g) and rats [(200 ± 20) g], of either sex 
were obtained from the Yash farms, Pune. The animals were 
kept in polyethylene cages in the departmental animal house 
at (26±2) ℃ and relative humidity 40%-55% with 12 h light 
and dark cycles. The animals were fed with regular pellet 
chow diet (Hind liver) and were allowed free access to water. 
Every experimental protocol for animal care procedures were 
approved by the Institutional Animal Ethical Committee 
(IAEC) with a protocol number MCP/IAEC/02/2009. 
2.5. Acute toxicity studies 
  Swiss albino mice weighing 20-25 g were taken for the 
study. The animals were divided into three groups. The 
animals were fasted overnight but were allowed free access 
to water prior to the day of study. First group served as 
control and received 1% carboxymethyl cellulose (CMC) in 
distilled water. While the other two groups received 2 g/kg 
p.o. dose of LAM and LAW, respectively. The extracts were 
suspended in 1% CMC solution in distilled water as they 
were not easily soluble in water.
  The animals were observed for 5 min every 30 min till 
2 h and then at 4, 8 and 24 h to detect any change in the 
autonomic or behavioral response and also for tremors, 
convulsion, salivation, diarrhea, lethargy, sleep and 
coma and then were further observed daily for 14 days for 
mortality[9]. 
2.6. Experimental induction of NIDDM and gastric ulcers in 
rats 
  Type II diabetes was induced by injecting a single i.p. dose 
of nicotinamide (120 mg/kg) followed by i.p. administration 
of STZ (65 mg/kg) in 0.1 M citrate buffer (pH 4.5). The fasting 
blood glucose level was estimated after 72 h from STZ 
administration. Rats exhibiting blood glucose concentration 
more than 145 mg/dL were considered diabetic and were 
included in the study. All the diabetic rats included in the 
study were administered with aspirin (200 mg/kg, p.o.) for the 
initial 7 days[6]. 
2.7. Experimental procedure
  The animals were separated into 10 groups each 
containing six. A total of 76 rats (6 normal + 54 diabetic) 
were used. Group 1 was normal untreated rats and received 
1% CMC solution. Except the normal group remaining 9 
groups contained STZ (65 mg/kg, i.p.) induced diabetic 
rats intoxicated with aspirin (200 mg/kg, p.o.). Group 2 
represented STZ+aspirin control group and rats housed in 
this group did not received any treatment. Group 3 animals 
were treated with glibenclamide (0.25 mg/kg, p.o.) whereas 
group 4 rats were treated with a daily dose of ranitidine
(2.5 mg/kg, p.o.). Group 5, 6 and 7 were administered with 
an oral dose of 100, 200 and 400 mg/kg, respectively,
L. acutangula MeOH extract. The groups 8, 9 and 10 were fed 
with an oral dose of 100, 200 and 400 mg/kg of L. acutangula 
aqueous extract, respectively[10]. 
2.8. Scoring of ulcer index
  On the 28th day, animals were sacrificed by cervical 
dislocation and the stomach was isolated and incised along 
the greater curvature and examined for ulcers. The greatest 
length of each lesion was measured and the sum of the 
lengths of all lesions in each stomach was reported as the 
ulcer index. The % inhibition of ulcer was determined and 
mean ulcer score for every animal was expressed as ulcer 
index[10,11]. Entire measurements were made by a person 
unaware about the treatment the rats were receiving[12]. The 
% inhibitions of ulcer were calculated and mean ulcer score 
for each animal was expressed as ulcer index[13]. 
2.9. Determination of percent protection 
  % Protection = [(STZ+aspirin control ulcer index) - (drug 
treated ulcer index)]/(STZ+aspirin control ulcer index) × 100.
  The number of ulcers per stomach was recorded and the 
percent of ulcer incidence of each group as compared to the 
STZ+aspirin control was calculated[10,11]. 
2.10. Determination of fasting blood glucose and serum 
insulin levels 
  The blood glucose levels were estimated on 0th, 14th and 
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28th day after induction of NIDDM. Blood was collected from 
the retro-orbital plexus and glucose was estimated by means 
of glucostix (One touch Ultra, Johnson and Johnson). Serum 
insulin was estimated merely on the 28th day to investigate 
the secretogouge effect of LA extracts[6,7,10,14]. 
2.11. Determination of mucosal glycoproteins
Glycoproteins were isolated from the samples of gastric 
mucosal scraping according to the method described by 
Pimple et al, 2012[10] 
2.12. Superoxide dismutase (SOD) and catalase (CAT) 
enzyme assay 
SOD and Catalase enzyme estimation was performed 
according to the established procedure of Kakkar et al, 
1984[15] and Kaur et al, 2006[16], respectively. 
2.13. Statistical analysis
The above estimations were analyzed statistically by 
applying One-way analysis of variance (ANOVA) followed by 
Dunnet’s test for multiple comparisons. The differences were 
considered significant when P<0.05.
3. Results
3.1. Effect of LA extracts on ulcer index and percent protection
  The diabetic rats on administration with LA extracts for 
21 days showed noticeable protection of the gastric mucosa 
against the acid attack. LAM at a dose of 200 and 400 mg/kg
and LAW at a dose of 400 mg/kg were found to protect 
the gastric mucosa significantly (P<001). The LAM 100, 
LAW 100 and 200 groups were in efficient in reducing the 
mucosal damage. The dose level of 100 mg/kg of LAM and 
LAW were not effective enough to treat the ulcers. Table 
1 highlights the curative effect of various LA extracts on 
gastric ulceration. Glibenclamide was less effective (P<0.05) 
in protection of ulcers as compared to the LAM (Table 1). 
3.2. Effect of different LA extracts on fasting blood glucose 
levels in diabetic rats
  The blood glucose was estimated after regular intervals 
to determine the antidiabetic effect of LA extracts. The 
LAM extract exhibited dose dependent promising (P<0.01) 
antidiabetic activity whereas the LAW 100 and 200 groups 
did not respond in depleting the glucose level. But the LAW 
400 group showed considerable (P<0.05) lowering in fasting 
blood glucose level. The LAM treated and LAW 400 groups 
were more efficient than ranitidine group in lowering the 
elevated glucose level (Table 2).
3.3. Effect of LA extracts on serum insulin and glycosylated 
hemoglobin
  The groups receiving ranitidine, LAW 100 mg/kg and LAW 
200 did not show any alteration in STZ-induced depletion 
of serum insulin. On the other hand each dose of LAM 
exhibited elevation of serum insulin which was comparable 
to glibenclamide (P<0.01). The LAM 100 and LAW 400 
group exhibited considerable (P<0.05) rise in serum insulin 
level and the LAM 200 and 400 group significantly (P<0.01) 
elevated the lowered serum insulin. Similar effects were also 
observed in case of glycosylaed hemoglobin (HbA1C). Table 
3 reveals the comparative effect of LAM and LAW on serum 
insulin and HbA1c (Table 3).
3.4. Effect of LA extracts on gastric mucosal glycoproteins
  The glibenclamide and LAW treated groups were less 
efficient in restoring the mucosal parameters to their normal 
values. A dose dependant significant (P<0.01) effect of 
LAM extracts were comparable to ranitidine a well known 
antiulcer drug in restoring the mucosal glycoproteins to 
normal levels. Overall the LAM scored well over LAW in 
treatment of mucosal damage induced by aspirin (Table 4).
Table 1
Effect of LA extract on ulcers index and percent protection of diabetic rats (mean依SEM, n = 6). 
Groups Ulcer index % Protection
Normal - -
STZ + aspirin control 62.1依3.3 ** -
Glibenclamide 51.5依2.3 * 17.07
Ranitidine 15.4依1.2 ** 75.20
LAM 100 48.8依3.6 * 21.42
LAM 200 27.2依3.5 ** 56.20
LAM 400 23.2依1.8 ** 62.64
LAW 100 58.3依3.8   6.12
LAW 200 54.1依3.1 12.88
LAW 400 50.2依2.4 * 19.16
LAM 100, LAM 200 and LAM 400 are oral doses of MeOH extract of L. acutangula in 100, 200 and 400 mg/kg respectively; LAW 100, 
LAW 200 and LAW 400 are oral doses aqueous extract of L. acutangula in 100, 200 and 400 mg/kg respectively. ** = P < 0.01, * = P < 0.05 
compared to STZ+aspirin control group. 
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3.5. Effect of LA extracts on antioxidant enzymes SOD and 
CAT
  The SOD enzyme levels were equally but significantly 
(P<0.01) elevated in animals treated with 400 g/kg dose of 
LAM and LAW. The groups receiving 200 mg/kg dose of LAM 
was effective (P<0.05) in restoring the SOD levels to normal. 
The LAM 100, LAW 100 and LAW 200 groups were totally 
inefficient in elevating the depleted SOD levels to normal.
  The distinct elevation in the CAT enzymes was observed 
in the by the groups treated with 200 and 400 mg/kg dose 
of LAM. The groups receiving LAM at 100 mg/kg and LAW 
at 100 and 200 mg/kg dose did not exhibit significant rise 
in CAT enzyme level.  In both the cases the LAM extracts 
superseded the ranitidine treated group. Table 5 highlights 
the effect of LAM and LAW on antioxidant enzyme level.
Table 2 
Effect of different LA extracts on blood glucose level in diabetic rats (mean依SEM, n = 6).
Groups
Fasting blood glucose level (mg/dL)
0th day 28th day
Normal 78.0依7.6      81.0依6.4 **
STZ + aspirin control 254.0依22.3  266.0依23.1
Glibenclamide 261.0依18.6      85.0依8.2 **
Ranitidine 250.0依20.7  228.0依14.8 
LAM 100 255.0依10.3    132.0依12.7 *
LAM 200 262.0依14.6     111.0依15.6 **
LAM 400 253.0依20.1     100.0依11.2 **
LAW 100 258.0依18.4  210.0依10.4 
LAW 200 252.0依28.3  165.0依12.4 
LAW 400 266.0依23.2    141.0依11.2 *
LAM 100, LAM 200 and LAM 400 are oral doses of MeOH extract of L. acutangula in 100, 200 and 400 mg/kg respectively; LAW 100, 
LAW 200 and LAW 400 are oral doses aqueous extract of L. acutangula in 100, 200 and 400 mg/kg respectively. ** = P < 0.01, * = P < 0.05 
compared to STZ+aspirin control group.
Table 3 
Effect of LA extracts on serum insulin and glycosylated hemoglobin (HbA1c) level in normal and NIDDM rats(mean依SEM, n = 6).
Groups Serum Insulin(mg/dL) HbA1c(毺U/mL)
Normal 15.50依0.62 ** 0.51依0.02 **
STZ + aspirin control   5.10依0.31 0.88依0.03
Glibenclamide 14.20依0.71 ** 0.55依0.02 **
Ranitidine   5.80依0.45 0.79依0.02 
LAM 100   8.10依0.45 * 0.74依0.03 *
LAM 200   9.10依0.25 ** 0.63依0.03 **
LAM 400 11.20依0.35 ** 0.58依0.02 **
LAW 100   5.90依0.35 0.82依0.02 
LAW 200   6.10依0.31 0.76依0.03 
LAW 400   7.90依0.10 * 0.65依0.02 **
LAM 100, LAM 200 and LAM 400 are oral doses of MeOH extract of L. acutangula in 100, 200 and 400 mg/kg respectively; LAW 100, 
LAW 200 and LAW 400 are oral doses aqueous extract of L. acutangula in 100, 200 and 400 mg/kg respectively. ** = P < 0.01, * = P < 0.05 
compared to STZ+aspirin control group. 
Table 4 
Effect of LA extracts on gastric mucosal glycoproteins (mean依SEM, n = 6).
Total hexose Hexos-amine Fucose Sialic acid Total carbo-hydrates(TC) Total proteins(TP) TC:TP
Normal 2 865依121** 1 755依33** 307依14** 117依9** 4 788依129** 6 112依210** 0.78依0.05**
STZ+aspirin control 2 117依117 1 480依45 202依17   54依8 3 987依248 7 310依220 0.55依0.04
Gliben-clamide 2 675依126* 1 685依63* 274依22   92依5* 4 681依147 6 610依321 0.71依0.03 *
Ranitidine 2 790依154** 1 780依33** 327依29** 113依10** 4 826依185* 6 187依146** 0.78依0.03**
LAM 100 2 640依133* 1 622依51 261依15   89依11 4 533依162 6 370依214* 0.71依0.04*
LAM 200 2 690依120* 1 660依44 289依17* 103依8** 4 581依134 6 310依211* 0.73依0.03**
LAM 400 2 760依131** 1 695依42* 321依12** 123依7** 4 621依120* 6 255依118** 0.74依0.02**
LAW 100 2 626依105* 1 596依65 255依21   81依10 4 644依188* 6 385依210* 0.73依0.03**
LAW 200 2 684依93* 1 632依61 272依28   95依9* 4 660依177* 6 342依166* 0.73依0.04**
LAW 400 2 710依133* 1 680依36* 305依23** 111依12** 4 715依230* 6 280依245** 0.75依0.03**
LAM 100, LAM 200 and LAM 400 are oral doses of L. acutangula MeOH extract in 100, 200 and 400 mg/kg respectively whereas;  LAW 100, 
LAW 200 and LAW 400 are oral doses of L. acutangula aqueous extract in 100, 200 and 400 mg/kg respectively. ** P < 0.01, * P < 0.05 
compared to respective normal and NIDDM-control groups.
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4. Discussion
  Our previous work demonstrates the impact of diabetes 
on the ulcer healing process[10]. LAM revealed significant 
reduction in the ulcer index of diabetic rats justifying that 
it is a step ahead over the drugs which have either only 
antiulcer (ranitidine) or only antidiabetic (glibenclamide) 
effects. The potential of LAM in depleting the aspiring 
induced damage could be attributed to the high amount of 
phenolics and flavonoids in it as compared to LAW[7]. 
  Diabetes is coupled with decrease in antioxidant status, 
glycoproteins, mucin secretion and mucosal cell shedding 
lacking any effect on cell proliferation[17,18]. Hence, in 
diabetes mucosal defensive factors play a very important role 
in escalating propensity to gastric ulceration and this may 
perhaps be one of the reasons for ranitidine to be effective 
in gastric ulceration in diabetic rats. LAM significantly 
(P<0.01) restored the mucosal glycoprotein in diabetic rats as 
compared to LAW. The potency of LAM was almost similar to 
raniditine. 
  STZ (65 mg/ kg) along with nicotinamide causes fractional 
destruction of pancreatic 毬-cells[10]. The antidiabetic 
action of LAM could be due to motivation of insulin 
discharge from the normal pancreatic 毬-cells. This is 
evident from the fact that LAM significantly uplifted the 
serum insulin concentration as compared to the LAW. 
The maintenance of blood glucose level at almost normal 
level could thus possibly protect the NIDDM patient from 
peptic ulceration[18]. Earlier reports also reveal that STZ 
significantly decreases the gastric blood flow[19-21]. 
  Many mechanisms have been postulated for the 
increased vulnerability of gastric mucosa of diabetic 
animals to damaged, which includes the destruction of the 
antioxidative system in the gastric mucosa[22], the inhibition 
of basic fibroblast growth factor production in the gastric 
mucosa, impaired duodenal HCO3
- discharge[23], decreased 
angiogenesis and the malfunction of capsaicin-sensitive 
afferent neurons engaged in the protection of gastric 
mucosa[24]. 
  Insulin is essential for cellular proliferation in devitalized 
tissue. The main action of insulin is not only to cleanse the 
wound of exudates and necrotic tissue but also to serve as 
a hormone by stimulating tissue regeneration[25]. Insulin 
enhances metabolism leading to mitosis and cellular 
proliferation of adjacent tissues[26]. Insulin considerably 
increases gastric mucosal blood flow in diabetic rats[27]. 
Serum insulin levels in group treated with LAM were 
significantly higher than LAW treated groups. Thus the 
elevation was comparable to glibenclamide suggesting the 
secretogouge role of LAM. 
  Prolonged elevated blood glucose level may lead in 
glycosylation of Hb[28]. When LAM was administered for 21 
days, an efficient sinking of glycosylated Hb level were seen 
in diabetic rats, thus signifying its usefulness in correcting 
the hazardous complications of diabetes.
  SOD and CAT play a vital role in detoxification of 
superoxide anion and H2O2 respectively, thus shielding cell 
against OFRs-induced damage[29]. The reactive superoxide 
radicals are first converted to H2O2 by SOD. Later these 
H2O2 radicals are scavenged by CAT to prevent the lipid 
peroxidation resulting due to generation of hydroxyl 
radicals[30]. LAM effectively elevated the concentration of 
these endogenous antioxidant enzymes as compared to LAW, 
thereby supporting the process of ulcer healing in diabetic 
rats. 
  Throughout the study the LAM superseded LAW in all 
aspects, which could be attributed to the presence of 
excess amount of phenolic or polyphenolic groups such as 
tannins or flavonoids. LA has been previously reported to 
contain antioxidants like tannins, hydroquinone, phenolic 
glycosides[7, 8]. 
  Additional investigation on derangement in the state of 
mucosal defensive factors such as cell shedding and tissue 
damage due to enhanced lipid peroxidation in diabetes 
may possibly throw extra light on the precise mechanism of 
action of LA. 
  It can be concluded that beneficial effects of L. acutangula 
in diabetic rats with co-existing gastric ulcer might be 
due to its dual nature i.e. antidiabetic (reversing the toxic 
consequence of diabetes on gastric mucosa) and direct 
promoting effect on the gastric mucosal protection.
Table 5 
Effect of LA extracts on endogenous antioxidant enzyme level (mean依SEM, n = 6).
Groups SOD(U/g of wet tissue) CAT(U/g of wet tissue)
Normal       97.3依4.2 **      27.3依1.1 **
STZ+aspirin control    48.2依5.1   11.3依0.8
Glibenclamide       66.4依3.2 **      18.2依0.8 **
Ranitidine    52.6依2.5   24.3依0.9 
LAM 100    46.6依3.2     16.5依1.3 *
LAM 200      67.3依4.4 *      17.9依1.1 **
LAM 400       84.4依5.1 **      21.5依2.2 **
LAW 100   52.3依2.9   10.2依1.4 
LAW 200   57.6依1.8   12.1依1.5 
LAW 400      78.4依2.3 **     17.5依0.9 *
LAM 100, LAM 200 and LAM 400 are oral doses of L. acutangula MeOH extract in 100, 200 and 400 mg/kg respectively whereas;  LAW 100, 
LAW 200 and LAW 400 are oral doses of L. acutangula aqueous extract in 100, 200 and 400 mg/kg respectively. ** P < 0.01, * P < 0.05 
compared to respective normal and NIDDM-control groups. 
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